Cost of Viberzi in 2025: Discounts and Offers Available
In the realm of brand-name drugs, Viberzi stands out as a treatment option for Irritable Bowel Syndrome with Diarrhea (IBS-D). However, its cost can be a concern for many patients, particularly those without insurance.
Without insurance, the average cost for a 60-tablet supply of Viberzi, whether 75 mg or 100 mg tablets, is approximately $1,696. But for eligible commercially insured patients, the Viberzi Savings Program can significantly reduce this cost to around $30 per 30-day prescription, with an annual savings cap of $10,771.
The price of Viberzi is influenced by several factors. Insurance coverage is a key determinant, with commercial insurance often providing copay assistance programs, whereas uninsured patients typically pay the full retail price.
The distribution channel also plays a role, as Viberzi is primarily distributed through hospital pharmacies, which may incur higher costs due to integrated care infrastructure and operating expenses.
Drug pricing tiers and formularies set by insurance companies can affect copays and out-of-pocket costs. Specialty-tier designations, such as Medicare Part D Tier 5, can impact these costs.
Manufacturer savings programs, like the Viberzi Savings Program, can substantially lower patient costs for those who qualify. However, it's important to note that Viberzi's patent will expire in 2033, which could lead to a significant decrease in prices once generic versions become available.
Regional market dynamics, particularly the U.S. market's dominance in IBS treatment usage, may also influence pricing strategies.
To save money on Viberzi, consider getting a 3-month supply, using a mail-order pharmacy, or seeking financial and insurance assistance. For more information about Viberzi's savings program, call 844-300-6286 or visit the program website.
It's crucial to remember that every patient's situation is unique, and the actual cost of Viberzi depends on insurance coverage, pharmacy type, patient eligibility for assistance programs, and upcoming generic competition. To get a clearer picture of what you'd pay for Viberzi with or without insurance, it's recommended to discuss with your doctor, pharmacist, or insurance provider.
For more information about IBS with diarrhea, visit the IBS hub. To learn more about drug cost and Viberzi, check out this article. For questions about the prior authorization process, contact your doctor or insurance provider. Always consult a licensed healthcare professional before taking any medication.
Lastly, it's worth mentioning that Optum Perks offers price estimates for Viberzi when using coupons from their site. However, these coupons cannot be used with insurance benefits or copays. For more information about Medicare drug coverage, read articles about Medicare prescription drug plans, drug coupons and Medicare, and the Medicare drug list.
- AbbVie, the manufacturer of Viberzi, offers the Viberzi Savings Program for eligible commercially insured patients, potentially reducing the cost of a 30-day prescription from $1,696 to around $30.
- For uninsured patients, the price of Viberzi can be significantly higher, with an average cost of approximately $1,696 for a 60-tablet supply, compared to around $30 for insured patients with access to the savings program.
- In the realm of health insurance and health providers, understanding the intricacies of drug pricing tiers and formularies set by insurance companies can help patients manage out-of-pocket costs and copays, such as those designated in Medicare Part D Tier 5.
- In the context of health-and-wellness, it's crucial to remember that every patient's situation is unique, and factors such as insurance coverage, pharmacy type, and patient eligibility for assistance programs play a crucial role in determining the actual cost of Viberzi.
- Finance-wise, exploring alternative options like getting a 3-month supply, using a mail-order pharmacy, or seeking financial and insurance assistance can help patients save money on their Viberzi expenses, but it's important to engage in discussions with doctors, pharmacists, or insurance providers to gain a clearer understanding of the cost implications.
